Skip to main content

Advertisement

Log in

Endoscopic versus microscopic approach for surgical treatment of acromegaly

  • Original Article
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Transsphenoidal surgery in the setting of acromegaly is quite challenging due to increased soft tissue mass, bony overgrowth, and bleeding. There is a debate on the endoscopic versus microscopic approach for these patients. The purpose of our study is to compare the outcomes for acromegaly after transsphenoidal surgery using both techniques. Retrospective review of 65 acromegalic patients who underwent transsphenoidal surgery in our department. Clinical remission was defined as resolution of typical acromegalic symptoms. Radiological resection was defined by volumetric criteria, and biochemical remission was defined as by the 2010 consensus on the criteria for remission of acromegaly. There was no significant difference in age, preoperative endocrine status, percent of macro adenomas, suprasellar, or infrasellar extension between both groups. Patients were assigned to both groups based on our existing referral pattern. Endoscopic approach was performed in 42 patients, while the microscopic approach was performed in 23 patients. No significant difference in remission rates was found between both groups (45.2 vs. 34.7 %, p = 0.40). The endoscopic group, however, had a significantly higher rate of gross total resections (61 vs. 42 %, p = 0.05). There was also a trend towards higher rates of gross total resections when cavernous sinus was present (48 vs. 14.2 %, p = 0.09). Postoperative diabetes insipidus occurred more in microscopic patients (34.7 vs. 17 %, p = 0.05), otherwise there was no significant difference in rates of complications. The median follow-up period was 56.6 months (range 6–156, mean 66.1). There is no significant difference in the rates of biochemical remission between the endoscopic and microscopic techniques. The endoscope technique, however, seems to be superior in achieving gross total resection especially with tumors invading the cavernous sinus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83:3411–3418

    Article  CAS  PubMed  Google Scholar 

  2. Beauregard C, Truong U, Hardy J, Serri O (2003) Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf) 58:86–91

    Article  Google Scholar 

  3. Bohinski RJ, Warnick RE, Gaskill-Shipley MF, Zuccarello M, van Loveren HR, Kormos DW, Tew JM Jr (2001) Intraoperative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery. Neurosurgery 49:1133–1143, discussion 1143–4

    CAS  PubMed  Google Scholar 

  4. Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ (2010) Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Neurosurg Focus 29:E5

    Article  PubMed  Google Scholar 

  5. Ceylan S, Koc K, Anik I (2010) Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus. J Neurosurg 112:99–107

    Article  PubMed  Google Scholar 

  6. Cusimano MD, Fenton RS (1996) The technique for endoscopic pituitary tumor removal. Neurosurg Focus 1:e1, discussion 1p following e3

    Article  CAS  PubMed  Google Scholar 

  7. Cusimano MD, Kan P, Nassiri F, Anderson J, Goguen J, Vanek I, Smyth HS, Fenton R, Muller PJ, Kovacs K (2012) Outcomes of surgically treated giant pituitary tumours. Can J Neurol Sci 39:446–457

    Article  PubMed  Google Scholar 

  8. De P, Rees DA, Davies N, John R, Neal J, Mills RG, Vafidis J, Davies JS, Scanlon MF (2003) Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission. J Clin Endocrinol Metab 88:3567–3572

    Article  CAS  PubMed  Google Scholar 

  9. Esposito V, Santoro A, Minniti G, Salvati M, Innocenzi G, Lanzetta G, Cantore G (2004) Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients. Neurol Sci 25:251–256

    Article  CAS  PubMed  Google Scholar 

  10. Frank G, Pasquini E (2006) Endoscopic endonasal cavernous sinus surgery, with special reference to pituitary adenomas. Front Horm Res 34:64–82

    PubMed  Google Scholar 

  11. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526–529

    CAS  PubMed  Google Scholar 

  12. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S, Acromegaly Consensus Group (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141–3148

    Article  CAS  PubMed  Google Scholar 

  13. Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T (2010) Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Neurosurg Focus 29:E7

    Article  PubMed  Google Scholar 

  14. Hardy J, Somma M (1979) Acromegaly: surgical treatment by trans-sphenoidal microsurgical removal of the pituitary adenoma. In: Tindall G, Collins W (eds) Clinical management of pituitary disorders. Raven Press, New York, pp 209–217

    Google Scholar 

  15. Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH (2010) Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas. Neurosurg Focus 29:E6

    Article  PubMed  Google Scholar 

  16. Kim MS, Jang HD, Kim OL (2009) Surgical results of growth hormone-secreting pituitary adenoma. J Korean Neurosurg Soc 45:271–274

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610–617, discussion 617–8

    Article  CAS  PubMed  Google Scholar 

  18. Kreutzer J, Vance ML, Lopes MB, Laws ER Jr (2001) Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 86:4072–4077

    Article  CAS  PubMed  Google Scholar 

  19. Long H, Beauregard H, Somma M, Comtois R, Serri O, Hardy J (1996) Surgical outcome after repeated transsphenoidal surgery in acromegaly. J Neurosurg 85:239–247

    Article  CAS  PubMed  Google Scholar 

  20. Ludecke DK, Abe T (2006) Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations. Neuroendocrinology 83:230–239

    Article  PubMed  Google Scholar 

  21. Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355:2558–2573

    Article  CAS  PubMed  Google Scholar 

  22. Nimsky C, von Keller B, Ganslandt O, Fahlbusch R (2006) Intraoperative high-field magnetic resonance imaging in transsphenoidal surgery of hormonally inactive pituitary macroadenomas. Neurosurgery 59:105–114, discussion 105–14

    Article  PubMed  Google Scholar 

  23. Nomikos P, Buchfelder M, Fahlbusch R (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure. Eur J Endocrinol 152:379–387

    Article  CAS  PubMed  Google Scholar 

  24. Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom acromegaly study group. J Clin Endocrinol Metab 83:2730–2734

    CAS  PubMed  Google Scholar 

  25. Rudnik A, Zawadzki T, Wojtacha M, Bazowski P, Gamrot J, Galuszka-Ignasiak B, Duda I (2005) Endoscopic transnasal transsphenoidal treatment of pathology of the sellar region. Minim Invasive Neurosurg 48:101–107

    Article  CAS  PubMed  Google Scholar 

  26. Schwartz TH, Anand VK (2007) The endoscopic endonasal transsphenoidal approach to the suprasellar cistern. Clin Neurosurg 54:226–235

    PubMed  Google Scholar 

  27. Shimon I, Cohen ZR, Ram Z, Hadani M (2001) Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48:1239–1243, discussion 1244–5

    CAS  PubMed  Google Scholar 

  28. Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA Jr (2013) Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J Clin Endocrinol Metab 98:3190–3198

    Article  CAS  PubMed  Google Scholar 

  29. Tabaee A, Anand VK, Barron Y, Hiltzik DH, Brown SM, Kacker A, Mazumdar M, Schwartz TH (2009) Endoscopic pituitary surgery: a systematic review and meta-analysis. J Neurosurg 111:545–554

    Article  PubMed  Google Scholar 

  30. Theodosopoulos PV, Leach J, Kerr RG, Zimmer LA, Denny AM, Guthikonda B, Froelich S, Tew JM (2010) Maximizing the extent of tumor resection during transsphenoidal surgery for pituitary macroadenomas: can endoscopy replace intraoperative magnetic resonance imaging? J Neurosurg 112:736–743

    Article  PubMed  Google Scholar 

  31. Trepp R, Stettler C, Zwahlen M, Seiler R, Diem P, Christ ER (2005) Treatment outcomes and mortality of 94 patients with acromegaly. Acta Neurochir (Wien) 147:243–251, discussion 250–1

    Article  CAS  Google Scholar 

  32. Yano S, Kawano T, Kudo M, Makino K, Nakamura H, Kai Y, Morioka M, Kuratsu J (2009) Endoscopic endonasal transsphenoidal approach through the bilateral nostrils for pituitary adenomas. Neurol Med Chir (Tokyo) 49:1–7

    Article  Google Scholar 

  33. Zada G, Cavallo LM, Esposito F, Fernandez-Jimenez JC, Tasiou A, De Angelis M, Cafiero T, Cappabianca P, Laws ER (2010) Transsphenoidal surgery in patients with acromegaly: operative strategies for overcoming technically challenging anatomical variations. Neurosurg Focus 29:E8

    Article  PubMed  Google Scholar 

  34. Zhao B, Wei YK, Li GL, Li YN, Yao Y, Kang J, Ma WB, Yang Y, Wang RZ (2010) Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases. J Neurosurg 112:108–117

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge Dr. Gerald Lebovic’s assistance with the statistical analysis.

Disclosure

The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hussein Fathalla.

Additional information

Comments

Martin Bettag, Trier, Germany

This is a single-institution retrospective study on the results of transsphenoidal surgery in GH-producing pituitary adenomas causing acromegaly. Patients were either operated on with the aid of a microscope (n = 23) or an endoscope (n = 42), and the results were compared. Basically, the results showed no significant difference in the rate of gross total tumor resection and also in the rate of biochemical remission. In the subgroup of parasellar extension into the cavernous sinus, there was a tendency of higher gross total resection rate in the endoscopic group. In view of complications, in the microscopic group, there was a significant higher rate of temporary as well as permanent diabetes insipidus.

The main disadvantage of this study is the fact that it is non-randomized and only two surgeons were involved, each one of them performed only one technique. The rate of temporary (34.7 %) and permanent (17.3 %) diabetes insipidus in the microscopic group is much higher than otherwise reported in the literature. So, this may be rather a surgeon-related than a technique-related complication. Also, the number of patients is fairly low. Gross total tumor resection is an important goal, but much more important is the rate of biochemical remission. In the endoscopic group, the overall remission rate was 45.2 %. More than a half of the patients in the endoscopic group could not be cured surgically. We have to accept that regardless of the mode of resection, biological factors do influence the rate of surgical cure rate in acromegaly. Patients with high preoperative GH levels and radiological signs of tumor invasion are less likely to achieve remission by surgery alone and most of them need an adjuvant multimodality treatment with medication and/or various forms of radiation therapy (1).

Literature

1. Robert M. Starke, Daniel M. S. Raper, Spencer C. Payne, Mary L. Vance, Edward H. Oldfield, John A. JaneJr. (2013) Endoscopic vs Microsurgical Transsphenoidal Surgery for Acromegaly: Outcomes in a Concurrent Series of Patients Using Modern Criteria For Remission. The Journal of Clinical Endocrinology & Metabolism 98:8, 3190–3198

Makoto Nakamura, Hannover, Germany

The authors present a retrospective study of 65 acromegalic patients who underwent transsphenoidal surgery using endoscopic or microscopic techniques. Patients were operated between 2000 and 2013 and were assigned to two senior pituitary surgeons. One surgeon routinely used the microscopic approach and the other surgeon the endoscopic approach. Two different operative techniques were provided according to the existing referral patterns. The endoscopic approach was performed in 42 patients, while the microscopic approach was performed in 23 patients. Despite of the retrospective nature of their study with its well-known limitations concerning interpretation of the results, interesting data are provided. The authors showed that there was no significant difference in the rates of biochemical remission between the endoscopic and microscopic techniques. However, gross total resection was more often achieved in tumors with cavernous sinus involvement using the endoscopic technique. Suprasellar or infrasellar extension of the tumor did not have any influence on GTR rates in both groups. When radical tumor removal (including the intracavernous portion of the tumor) is intended, better lateral visualization could be obtained with the endoscope. It needs to be pointed out that the rate of cavernous sinus invasion in this series was quite high with 49 %. Interestingly, concerning postoperative complications, DI was significantly higher in the microscopic group. It may be due to better visualization through the endoscope but on the other hand, new postoperative pituitary deficit of the anterior lobe was potentially higher in the endoscopic group (although not statistically significant), which is rather in contrast to the before mentioned. This retrospective study showed that the main goal of hormonal remission can be achieved with comparable success, either using the microscopic or endoscopic method, provided that surgery is performed by experienced pituitary surgeons. It will be of continuing interest, whether further implementation of HD and 3D techniques will have an impact on surgical outcome of these patients.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fathalla, H., Cusimano, M.D., Di Ieva, A. et al. Endoscopic versus microscopic approach for surgical treatment of acromegaly. Neurosurg Rev 38, 541–549 (2015). https://doi.org/10.1007/s10143-015-0613-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-015-0613-7

Keywords

Navigation